Society for Immunotherapy of Cancer (SITC) shared on LinkedIn:
“One week to go! The 2026 Society for Immunotherapy of Cancer EU Immuno-Oncology Drug Development Summit is almost here. Join leading experts Sept. 3–4 in Lausanne, Switzerland, for two days of insights, innovation and collaboration shaping the future of IO drug development.
This also can be interesting: BXCL701: Promising Innate Immune Activation, Dose, Administration, And Clinical Trials
